Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase II Emphasis
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Traumatic Stress and Alcohol Problems: Between- and Within- Person Associations
A bifunctional antibody screening system for both phage display and yeast two-hyb
Nanotechnology Platform for Targeting Solid Tumors
SCC-CIVIC-PG Track B Creating an Integrated Emergency and Crisis Response System
RUI: Collaborative Research: Laboratory Studies of Holdout and Efficiency in Multilateral Bargaining
Recently added grants:
Cellular and molecular mechanisms of diabetic atherosclerosis
Functional Genomics of Cardiac Sodium Channel Variants
A molecular and functional dissection of the vagal heart-to-brain physiological circuits
Tracking M2-Like Macrophages in Cardiopulmonary Diseases by Magnetic Resonance Imaging
A novel T7 phage display technology to detect sarcoidosis specific antigens
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM62201-5-0-2
Application #
7568588
Study Section
Project Start
2006-01-01
Project End
2008-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Early Therapeutics Development with Phase II Emphasis
/ University of Chicago
$662,981
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
Vokes, Everett E. /
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
$1,737,296
NIH 2007
N01 CA
Early Therapeutics Development with Phase II Emphasis
/
Comments
Be the first to comment on this grant